SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001445305-14-000088
Filing Date
2014-01-15
Accepted
2014-01-15 17:18:44
Documents
4
Period of Report
2014-01-15
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a2014reversesplit8-k.htm 8-K 25022
2 EXHIBIT 3.1 ex31coa.htm EX-3.1 19416
3 EXHIBIT 99.1 ex991pressrelease.htm EX-99.1 12696
4 a51145ljpclogo.jpg GRAPHIC 9450
  Complete submission text file 0001445305-14-000088.txt   71493
Mailing Address 4660 LA JOLLA VILLAGE DRIVE, SUITE 1070 SAN DIEGO CA 92122
Business Address 4660 LA JOLLA VILLAGE DRIVE, SUITE 1070 SAN DIEGO CA 92122 858-207-4264
LA JOLLA PHARMACEUTICAL CO (Filer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-24274 | Film No.: 14530451
SIC: 2836 Biological Products, (No Diagnostic Substances)